Treatment Regimen from Chernobyl Can Inform Doctors in Fukushima

According to German researchers, children from Belarus who developed thyroid cancer caused by the 1986 nuclear blast at Chernobyl have responded very well to an established regimen, potentially giving hope to survivors of the Fukushima nuclear reactor accident in 2011.

According to Christoph Reiners, MD, of the University of Wurzburg in Germany, and colleagues, out of over 200 children who were treated with a combination of surgical resection, iodine-131 therapy, and suppressive levothyroxine, 64 percent achieved complete remission, 30 percent had near-complete remission, and just five percent experienced partial remission. These results come after a median 11 year follow-up.

Only two recurrences were reported after partial remissions, and no patients died from thyroid cancer. That said, one patient did die from complications from the radioiodine therapy (advanced pulmonary fibrosis) 19 years after the initial diagnosis.

Their findings have been published online in the Journal of Clinical Endocrinology and Metabolism.

The authors wrote that:

Despite the unfavorable prognostic characteristics of our patients and their often suboptimal initial care, final treatment results after application of the state-of-the-art radioiodine therapy protocols were very good.

The 1986 explosion at Chernobyl released enormous amounts of radioactive cesium and iodine into the atmosphere and over the former states of the Soviet Union such as Belarus. The iodine release specifically is believed to have led to an elevated risk of thyroid cancer in younger people. The 2011 disaster at the Fukushima nuclear reactor in Japan is believed to have created a comparable public health problem. Investigators therefore believe that this study could help doctors who will be treating those victims of the 2011 fall-out.

Source: MedPage Today

Photo: "Combat Vehicle at the Militia Station," Timm Suess

More Articles

More Articles

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It presents itself in the mantle zone of lymph nodes...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

Lymphomas are classified based on the type of cells involved. Non-Hodgkin’s lymphomas are marked by mutations of...

Hodgkin's Lymphoma (Disease) has a colorful history: It was not the first cancer discovered but it was one of the first in which treatments were...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Cancer bracelets are undeniably popular, and if purchased through reliable sources such as major charities, they help contribute to the fight...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer of the b- and t-cell lymphocytes, part of the immune system. They account for the most frequent head and neck malignancies....

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

As a kind of cancer, lymphoma attacks the lymphocytes and lymph nodes that are part of the immune system. Head and neck lymphoma results when...

Some cancers have clear environmental causes. Oral cancer is strongly tied to the use of chewing tobacco, and lung cancer is well-known to be much...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...